FDA NDC Directory · JSON-LD · Markdown
NDC 69097-431 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE
| Generic name | Darifenacin Hydrobromide |
|---|---|
| Labeler / Manufacturer | Cipla USA Inc. |
| Marketing category | Abbreviated NDA (generic) · App ANDA207664 |
| Dosage form / route | TABLET, EXTENDED RELEASE · ORAL |
| Active ingredients | DARIFENACIN HYDROBROMIDE (7.5 mg/1) |
| Marketing started | 20160901 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).